コロナパンデミックは
人間家畜化計画を
体現する壮大な詐欺
どうもです。いよいよ大変な秘密が暴かれました！
↓この動画にすべてが詰まっております。字幕がありますので、【必ず】ご覧ください。
【衝撃】情報公開請求文書により、コロナパンデミックはオバマ政権期からの国防総省の作戦であったことが明らかに！
弊通信をお読みの方は、もう何が起こっても驚きませんね。がしかし、あらためて、、、
そうだったんかい！ って感じです。
ええ、ええ、全部仕込みです。「EVENT201」で既に知ってましたが。この情報公開請求文書でモロ確定した感じです。
えッ？ EVENT201をご存じない？あなたモグリですね。本記事の最後にご案内しますので、そちらをどうぞ。
動画を観るのが面倒という方のために、念のため重要部分をピックアップしておきますね。
(*´Д`)ﾊｧﾊｧ ちょっと休憩。
ここまでで、コロナ茶番に気が付かれている方は、「そうそう、そうねー」と納得感しかないですよね。
あ、大衆の認識操作については、こちらの記事もぜひ！
コロナ洗脳で使われたヤバい心理学テク＆用語一覧
続きいきましょう。
この「ワクチン」と呼ばれるトンデモナイ遺伝子治療用劇薬のmRNA注射が、全国民向けに導入された時、
「【インフォームド・コンセント】（治療される側への適切な薬についての説明）が、全然なされていないじゃないか！」
という問題点を弊通信でも取り上げていたのですが、アハハ、インフォームド・コンセント自体必要ない、ということにされていたとは…
アッパレ！
ええ、ええ、人間様は「家畜と同等」ということです。
ええ、ええ、まさにゴイム対応！
あ、ゴイムとは「人間の形をした動物」のことです。詳しくはこちら＞＞
うむ、こうなると「つべこべ言わずに打て！」も納得。こういう流れだったですね。家畜はつべこべ言わずにワクチン打たれてます。
そのうち鳥インフルが出た鶏舎のニワトリたちのように、人も平気で殺処分されるようになるかもしれないですね。
ちなみに、なんか最近はこういう「家畜と同等」みたいな言い方が、人間を上・それ以外の動物を下に見ているみたいで、家畜の皆さんに悪いな…なんて思ってしまう自分です。
そして、極めつけはコレ。
弊通信では度々、このコロナパンデミックを「コロナ感染症世界大戦」などと比喩的に揶揄してきましたが
本当の本当に「戦争」扱いだったのだ。
目下戦時中なのにそれを全く持って感知できない羊たちの皆さん、早く目覚められるといいですね。
これTwitterでの拾い物です。
そんでもって、こうなると気になるのはアメリカ以外、特に日本はどうなんじゃろう…ということです。
なんだかんだ思いを馳せていたら、首相官邸のサイト内にこんなのを発見しました。
国家安全保障の観点からの 純国産COVID-19ワクチンの重要性
2021年4月。うむ、アメリカに追随して出してみた感じでしょうか。余計なことをしおってからに。
がしかし、このスライド資料には、動画の理解を深めるための基礎知識がわかりやすくまとめてあった！凄い助かるぜ！故に丸パクリします。
この辺ですね。
しつこいようですが、日本で打ちまくられている新型コロナワクチンは、「未承認品」です。
ちなみにこの資料を提出した 日本製薬団体連合会はこのような組織です。
ふぅ～ん、って感じですね(*’ω’*)。
どこが一番のアメリカ(の中のDS)のポチなのか。29ページもありますが、ぜひぜひご一読ください。
国家安全保障の観点からの純国産COVID-19ワクチンの重要性（日薬連）
さらに！もっともっと情報がほしい方、次のもどうぞ。黒塗りも多いですが。
●動画で告発していた女性、サーシャ氏のサイト(substack) Sasha Latypova
お、これも。
あ、最後になりましたが（忘れてなかった）、「EVENT201って何？」というお花畑を歩んで来たそこのあなた！
もしもそんな方がいらっしゃいましたら、こちらの記事たちをご覧ください。
嘘でしょ？コロナパンデミックのシナリオを確認する事前会議「EVENT201」
【仕込み】「EVENT201」コロナのシナリオを確認する嘘みたいな事前会議
まあ、陰謀論って言われちゃうんですけどね。
現実逃避が好きな方々には…
以上です。
この記事も人気です
帯状疱疹と有名人｜コロナワクチン接種が原因バイアスはやめよう！
各自の接種歴も知りませんし、ま〜あ！バイアスに塗れた記事ですわ。でもどうしてもアレ……
続きを読む
続きを読む
Twitterで「ゴキブリ」がトレンド入りした理由
強い味方が増えました！？ こ、これです これの何処がゴキブリに関係あるのかわから……
続きを読む
続きを読む
河野太郎氏。僕は知りましぇん！責任は取りましぇん！
101回目のデマゴーク 正月早々、Twitterが【河野太郎氏ファイヤーフェス】と化していま……
続きを読む
続きを読む
「ワクチン危険」は大袈裟？ほとんどの接種者が何事もなく平和そうな理由
なにかと幸運が 重なった結果 これ以上の重ね打ちは 危険 いつも疑問だったんです……
続きを読む
続きを読む
【必見】「DIED SUDDENLY(突然死)」日本語字幕 ワクチン死は陰謀論なのか？
ハリウッド映画より、全然おもしろい界隈ドキュメンタリー。出てくるもの全部「本物」……
続きを読む
続きを読む
WHO、挑発的な動画を公開！「反ワクは殺人者！」
WHOがここに来て焦りを見せているようです。品位を微塵も感じない、変ショート動画を公開……
続きを読む
「ワクチン危険」は大袈裟？ほとんどの接種者が何事もなく平和そうな理由
「ワクチン危険」は大袈裟？接種者が何事もなく平和そうな理由５
【驚愕】ビオンテック社、重大な副作用、安全性と有効性に関するデータなしと認める
「全ての情報を開示すれば、打つ人は減ると思う」（byこびナビ峰宗太郎氏）
ファイザー有害事象報告書
超重要ファイザー公開の1291種類のコロナワクチン有害事象リスト
ワクチンで不妊は本当にデマ？有害事象(AESI)に「抗精子抗体陽性」
重要情報
おもな有害事象・副作用一覧
そしてこれ、大事なので何度でも貼る。兆候があったら病院行ってくださいね。
後日追記
サーシャ・ラティポワ（Sasha Latypova） – 政府、軍、バイオ製薬の産業複合体を取り上げる。「なぜ？」https://t.co/MZtoMJ0W2E
なぜ、自分たちの政府がこんなことをするのか？ なぜ、人類史上最悪の残虐行為を事前に計画し、実行するのでしょうか？ なぜ全世界の政府が同時に行うのでしょう？— Alzhacker (@Alzhacker) January 16, 2023
メモ
COVID-19 Contracts
United States of America>>>
Below are links to copies of the contracts entered into by the US government for technologies to combat the COVID-19 pandemic. KEI is updating this page as we gain access to more contracts, and less redacted versions. Agreements related to the Medical CBRN Defense Consortium (MCDC) whose agreements are executed by Advanced Technology International (ATI) are noted with “(via ATI)”.
KEI has also created a US COVID-19 contract spreadsheet to track metadata of the agreements, as well as to compare the terms contained therein for intellectual property rights, data, and other topics. (Note: At this time, this spreadsheet is being continually updated.)
KEI maintains a separate page of US government contracts concerning needle and syringe production related to the COVID-19 response.
The list below contains COVID-19-related contracts obtained via Freedom of Information Act requests, Securities & Exchange Commission filings, and HHS reading room files. The bulk of KEI’s database of contracts, however, was obtained via FOIA requests and lawsuits filed by KEI. Linked herein is a comprehensive list of all US government COVID-19-related contracts obtained by KEI via FOIA.
- Advanced Technology International (ATI) – Underlying contract to execute MCDC and COVID-19 contracts on behalf of the federal government.
- DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April 8, 2016.
- DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April 8, 2016. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
- Aerpio – respiratory condition treatment.
- DOD-Aerpio Statement of Work W81XWH1590001.
- DOD-Aerpio Project Approval Letter W81XWH1590001. July 28, 2020.
- Altimmune – therapeutic.
- DoD-Altimmune Project Approval Letter W81XWH159001. June 17, 2020.
- DoD-Altimmune Statement of Work W81XWH159001.
- DoD-Altimmune Revised Project Approval Letter (3) W81XWH159001. February 3, 2021.
- DoD-Altimmune Revised Project Approval Letter (2) W81XWH159001. December 15, 2020.
- America’s Blood Center – convalescent plasma.
- HHS/ASPR/BARDA-America’s Blood Center Contract 75A50120000094 (includes Mods 1-8). April 17, 2020.
- DOD-America’s Blood Centers Contract W911QY2190006. October 30, 2020.
- ANP Technologies – diagnostics.
- DoD-ANP Technologies Contract W911QY20D0019 (includes Mods 1-3). May 29, 2020.
- DOD-ANP Technologies Supply Order W911QY20D0019 (includes Mods 1-3). June 2, 2020.
- DOD-ANP Technologies Supply Order W911QY20P0141 (includes Mod 1). April 17, 2020.
- AstraZeneca – vaccine.
- HHS/ASPR/BARDA-AstraZeneca Advanced Agreement to Other Transaction Authority Agreement 75A501-20-C-00114. May 20, 2020.
- HHS/ASPR/BARDA-AstraZeneca Modification of OTA Agreement 75A501-20-C-00114 MODP00001. July 31, 2020.
- AstraZeneca – vaccine.
- DoD-AstraZeneca Other Transaction Authority Agreement W15QKN2191003. October 28, 2020.
- AstraZeneca – prophylactic monoclonal antibody.
- DOD-AstraZeneca Contract W911QY2190001 (includes Mods 1, 2, 3, and 5). October 9, 2020.
- AstraZeneca – therapeutic.
- DoD-AstraZeneca Contract W911QY20C0119 (includes Mod 1). September 30, 2020.
- DoD-AstraZeneca Contract W911QY20C0119 (includes Mod 1). September 30, 2020. (Version obtained by FOIA)
- Atlantic Diving Supply – no-contact thermometers.
- DOD-Atlantic Diving Supply Contract W911QY18D0019. September 16, 2020.
- Beckman Coulter – diagnostic-related.
- HHS/ASPR/BARDA-Beckman Coulter Contract 75A50119C00078. September 30, 2019.
- HHS/ASPR/BARDA-Beckman Coulter Contract 75A50119C00078-P00001. May 15, 2020.
- HHS/ASPR/BARDA-Beckman Coulter Contract 75A50120C00189. September 28, 2020.
- Biofire Defense – diagnostics.
- DoD-Biofire Defense Supply Order W911QY13D0080 Contract W911QY20F0271. April 24, 2020.
- DoD-Biofire Defense Supply Order W911QY13D0080 Contract W911QY20F0171 (includes Mods 1-2). May 23, 2020.
- DOD-Biofire Defense Supply Order W911QY20F0196 and W911QY20F0165 Contract W911QY13D0080 (includes Mod 1 of W911QY20F0196). April 17, 2020.
- BCG Federal Corp – COVID-19-related support services.
- DoD-BCG Federal Corp Contract W911QY20P0198. June 28, 2020.
- Centivax – therapeutic.
- DOD-Centivax Statement of Work W81XWH1590001.
- DOD-Centivax Project Approval Letter W81XWH1590001. August 19, 2020.
- Cepheid – test kits.
- DoD-Cepheid Contract W911QY20C0046 (includes Mods 1, 2, 3, 5, and 6). April 5, 2020.
- DoD-Cepheid Contract W911QY20P0154 (includes Mods 1-6). April 27, 2020.
- DoD-Cepheid Contract W911QY20P0195 (includes Mod 2). June 12, 2020.
- DoD-Cepheid Technical Direction Letter W15QKN1691002. September 14, 2020.
- DOD-Cepheid Contract W911QY20C0124 (includes Mods 1-5, Supply Order W911QY21F0116 (January 22, 2021) + 1 Mod, and Supply Order W911QY21F0205 (March 25, 2021)). September 24, 2020.
- ChemBio Diagnostic – antigen test.
- HHS/ASPR/BARDA-ChemBio Diagnostic Contract 75A50120C00138. July 3, 2020.
- HHS/ASPR/BARDA-ChemBio Diagnostic Contract 75A50120C00138-P00001. July 20, 2020.
- Controlant – services.
- DoD-Controlant Contract W911QX21C0010 (includes Mods 1-4). November 25, 2020.
- DoD-Controlant Contract W911QX21C0010 Mods 5, 7, and 8. May 10, 2021.
- Corning Incorporated – vaccine manufacturing supplies.
- DoD-Corning Contract W911NF2030004. June 5, 2020.
- Cue Health – diagnostics manufacturing supplies.
- DoD-Cue Health Other Transaction Authority Agreement W911NF2190001. October 13, 2020.
- Cue Health – diagnostics.
- HHS-Cue Health Contract HHSO100201800016C. June 4, 2018.
- HHS-Cue Health Contract HHSO100201800016C-P00001. September 1, 2019.
- HHS-Cue Health Contract HHSO100201800016C-P00002. March 21, 2020.
- HHS-Cue Health Contract HHSO100201800016C-P00003. May 13, 2020.
- HHS-Cue Health Contract HHSO100201800016C-P00004. September 22, 2020.
- Culmen – PPE.
- DOD-Culmen International Contract W911QY18D0042 (includes Mods 1-8). April 22, 2020.
- Cytiva (Global Life Sciences Solutions) – vaccine manufacturing supplies.
- DoD-Cytiva Contract W911NF2130001 (includes Mod 1). October 13, 2020.
- Cytovale – COVID-related sepsis assessment.
- HHS-Cytovale Contract 75A50119C00072. September 28, 2019.
- HHS-Cytovale Contract 75A50119C00072-P00001. April 7, 2020.
- Diasorin – assays.
- HHS/ASPR/BARDA-DiaSorin Contract 75A50120C00017. March 11, 2020.
- Diomics Corporation – diagnostics.
- DoD-Diomics Corporation Project Approval Letter W81XWH159001. August 17, 2020.
- DoD-Diomics Corporation Revised Project Approval Letter W81XWH159001. February 2, 2021.
- DoD-Diomics Corporation Statement of Work W81XWH159001.
- Eli Lilly – therapeutic.
- DoD-Eli Lilly Contract W911QY21C0016 (includes Mods 1-5). October 27, 2020.
- DOD-Eli Lilly Contract W911QY21D0012-P00002. April 7, 2021.
- DOD-Eli Lilly Contract W911QY21F0167-P00003. May 27, 2021.
- Emergent Biosolutions – convalescent plasma manufacturing and clinical studies.
- DOD-Emergent Biosolutions Canada Contract W911QY2090013 (includes Mod 1). June 24, 2020.
- Emergent Biosolutions – vaccine manufacturing.
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I. June 15, 2012. (Version obtained via SEC filing)
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I -Task Order 75A50120F33007. May 24, 2020. (Version obtained via SEC filing)
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I -Task Order 75A50120F33007. May 24, 2020. (Version obtained via FOIA)
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I-75A50120F33007-P00001. August 24, 2020.
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I-75A50120F33007-P00002. May 13, 2020.
- HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I-75A50120F33007-P00003. October 7, 2020.
- Emory University – therapeutic.
- DoD (via ATI)–Emory University Technical Direction Letter Other Transaction Authority W15QKN1691002. July 1, 2020.
- Empatica – diagnostics technology.
- HHS/ASPR/BARDA-Empatica Contract 75A50120C00132. June 18, 2020.
- Empatica – diagnostics technology.
- DoD-Empatica Project Approval Letter W81XWH159001. September 10, 2020.
- DoD-Empatica Statement of Work W81XWH159001.
- Evidation Health – COVID-19 detection and forecasting model.
- HHS/ASPR/BARDA-Evidation Health Contract 75A50120C00091. April 17, 2020.
- Federal Resources Supply – collection kits.
- DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911QY20F0215 (includes Mods 1-2). April 24, 2020.
- DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911QY20F0226 (includes Mods 1-3). May 4, 2020.
- DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911SR20F0039 (includes Mods 1-5). April 22, 2020.
- Fitbit – diagnostics technology.
- DoD-Fitbit Project Approval Letter W81XWH1590001. September 23, 2020.
- DoD-Fitbit Statement of Work W81XWH1590001.
- Flir – thermometers.
- DOD-Flir Commercial Contract W911QY20P0149. April 22, 2020.
- Fujifilm – therapeutic.
- DoD (via ATI)–Fujifilm Project Approval Letter 2009COVID19006 under Other Transaction Authority Agreement W81XWH1590001. July 9, 2020.
- DoD (via ATI)–Fujifilm Revised Project Approval Letter 2009COVID19006 under Other Transaction Authority Agreement W81XWH1590001. December 14, 2020.
- DoD (via ATI)–Fujifilm Statement of Work 2009COVID19006 under Other Transaction Authority Agreement W81XWH1590001. December 14, 2020.
- Genentech (Roche) -therapeutic.
- HHS/ASPR/BARDA-Genentech Other Transaction Authority Agreement HHSO100201800036C. September 27, 2018.
- HHS/ASPR/BARDA-Genentech Modification of OTA Agreement HHSO100201800036C. March 27, 2020.
- GenMark Diagnostics – diagnostic.
- HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022. March 20, 2020.
- HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022-P00001. May 28, 2020.
- HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022-P00002. July 20, 2020.
- GlaxoSmithKline – vaccines.
- DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048. July 30, 2020.
- DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00001. July 30, 2020.
- DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00002. September 16, 2020
- DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048. July 30, 2020.
- Global Life Sciences – vaccine supply manufacturing.
- DOD-Global Life Sciences Solution Contract W911NF2130001 P00003. July 29, 2021.
- Golden Max – infusion pump kits.
- DoD-Golden Max Contract W81XWH20D0057 (includes Mod 1). April 17, 2020.
- Grifols Therapeutics – convalescent plasma.
- DoD (via ATI)-Grifols Therapeutics Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. September 1, 2020.
- Grand River Aseptic Manufacturing (GRAM) – vaccine and therapeutic manufacturing.
- DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086-P00003. August 4, 2020.
- DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086 – Mods 3 and 1-5. August 4, 2020. (Version obtained via FOIA)
- DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086 Mods 1-5. September 1, 2020.
- Hologic – testing assays.
- HHS/ASPR/BARDA-Hologic Contract 75A50120P00069. April 29, 2020.
- HHS/ASPR/BARDA-Hologic Contract 75A50120P00100. August 7, 2020.
- HHS/ASPR/BARDA-Hologic Contract 75A50120P00100-P00001. October 29, 2020.
- Icon – clinical trials.
- DoD-Icon Other Transaction Authority Agreement W911QY2090007 (includes Mods 1 and 4). April 27, 2020.
- IIT Research Institute – tech transfer for virus neutralization assay.
- DOD-IIT Research Institute Contract W911QY21C0014. November 30, 2020.
- Immunome – antibody-related (redactions).
- DOD-Immunome Contract W911QY2090019. July 3, 2020.
- Inbios International – diagnostics.
- DoD-Inbios International Contract W81XWH20F0253 (includes Mod 1). June 15, 2020.
- Inbios – antibody diagnostic.
- HHS-InBios Contract 75A50120C00090. April 26, 2020.
- Inhalon Biopharma – inhaled prevention/therapeutic.
- DoD-Inhalon Biopharma Project Approval Letter W81XWH1590001. September 11, 2020.
- DoD-Inhalon Biopharma Statement of Work W81XWH1590001.
- Inovio Pharmaceuticals – vaccine delivery.
- DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version obtained from SEC filings)
- DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version obtained via FOIA request)
- DoD-Inovio Pharmaceuticals Other Transaction Authority Agreement W911QY2090016. June 22, 2020. (Version obtained from SEC filings)
- DOD-Inovio Pharmaceutical Other Transaction Authority Agreement W911QY2090016. June 22, 2020. (Version obtained via FOIA request)
- Johns Hopkins University – clinical trials of convalescent plasma.
- Johnson&Johnson (Janssen) – vaccine.
- HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement HHSO100201700018C. August 15, 2017. (Version obtained by FOIA March 31, 2021).
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 6. February 11, 2020.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 6. February 11, 2020. (Version obtained by FOIA March 31, 2021).
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 7. March 20, 2020.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 8. March 27, 2020.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 8. February 11, 2020. (Version obtained by FOIA March 31, 2021).
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendments 1, 2, 3 (dates redacted) 4 (date not listed), 5 (December 19, 2019), 9 (date not listed), 10 (August 21, 2020). (Version obtained by FOIA June 2021)
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 6. February 11, 2020. (Version obtained by FOIA June 2021)
- Johnson&Johnson (Janssen) – therapeutic.
- HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement HHSO100201800012C. September 21, 2018.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201800012C-Amendment 1. April 4, 2019.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201800012C-Amendment 2. August 1, 2019.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201800012C-Amendment 3. January 31, 2020.
- HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201800012C-Amendment 4. February 14, 2020.
- HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement HHSO100201800012C. September 21, 2018. (Version obtained via FOIA June 2021)
- Johnson&Johnson (Janssen) – vaccine.
- DoD (via ATI)-Janssen Other Transaction Authority Agreement W15QKN1691002-P00081. August 5, 2020.
- DoD (via ATI)-Janssen Other Transaction Authority Agreement W15QKN1691002-P00081-Mod00001. September 21, 2020. (Version obtained by FOIA)
- Just Evotec – therapeutic manufacturing.
- DOD-Just Evotec Contract W911QY2090015 (includes Mods 1-3). July 7, 2020.
- Kalman – labor support services.
- DOD-Kalman W911QY19F0147-P00042. March 1, 2021.
- KPMG – prototype process for mAb infusion capacity.
- DOD-KPMG W912CG2190001-P00001. June 16, 2021.
- Lumen Bioscience – therapeutic.
- DoD-Lumen Bioscience Project Approval Letter W81XWH1590001. July 24, 2020.
- DoD-Lumen Bioscience Revised Project Approval Letter (2) W81XWH1590001. August 11, 2020.
- DoD-Lumen Bioscience Revised Project Approval Letter (3) W81XWH1590001. December 9, 2020.
- DoD-Lumen Bioscience Revised Project Approval Letter (4) W81XWH1590001. February 4, 2021.
- DoD-Lumen Bioscience Statement of Work W81XWH1590001.
- Luminex – antibody assay.
- HHS/ASPR/BARDA-Luminex Contract 75A50120C00179. September 23, 2020.
- HHS/ASPR/BARDA-Luminex Contract 75A5012C00037. March 26, 2020.
- HHS/ASPR/BARDA-Luminex Contract 75A50120C00043. March 27, 2020.
- Maxim – diagnostics.
- DoD-Maxim Contract W911QY20D0018 (includes Mods 1-4). May 11, 2020.
- MBio – antibody diagnostic.
- HHS-MBio Diagnostics Contract 75A50120C00130. June 17, 2020.
- Merck Sharp & Dohme – vaccine.
- (Note: HHSO100201600031C began as a contract to Bioprotection Systems for an Ebola vaccine, Merck entered into a collaboration agreement with BPS in 2014)
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C. September 29, 2016.
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-Attachment 2-Milestones. May 19, 2017.
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-Attachment 1-Statement of Work. May 19, 2017.
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00001. April 27, 2017.
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00002. September 6, 2017.
- HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00003. May 23, 2018.
- HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00004. May 9, 2019.
- HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00005. April 14, 2020. (Version obtained March 2021 via FOIA lawsuit)
- HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00005. April 14, 2020.
- Merck Sharp & Dohme – therapeutic.
- DoD-Merck Sharp & Dohme Other Transaction Authority Agreement W911QY2190001. December 2, 2020.
- Merck Sharp & Dohme – therapeutic.
- DOD-Merck Sharp & Dohme Contract W911QY21C0031. June 7, 2021.
- Microbiologics – tech transfer for virus neutralization assay.
- DOD-Microbiologics Contract W911QY21C0012 (includes Mod 1). November 9, 2020.
- Minnesota Medical Warehouse – hand sanitizer.
- DOD-Minnesota Medical Warehouse Contract W911SR20P0010 (includes Mods 1-3). April 30, 2020.
- Moderna – vaccine.
- HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020.
- HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020. (Less redacted version obtained via FOIA lawsuit on February 8, 2021)
- HHS/ASPR/BARDA-Moderna Contract 75A50120C00034-P00003. July 25, 2020.
- Moderna – vaccine manufacturing.
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained from Moderna SEC filings)
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained October 29, 2020 from HHS FOIA Reading Room)
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained November 9, 2020 from HHS FOIA Reading Room)
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00001. August 9, 2020.
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00002. September 11, 2020.
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00003. December 11, 2020.
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00004. February 11, 2021. (Obtained via FOIA)
- DoD/ASPR/BARDA-Moderna Contract W911QY20C0100 – Mods 7-10. June 15, 2021.
- MRI Global – mobile medical laboratories.
- DOD-MRI Global Contract W911SR20F0054 – Mods 1-2. May 27, 2020.
- Murtech – diagnostics.
- DoD-Murtech Contract W911QY20D0017 (includes Mods 1-2). May 11, 2020.
- Nanomix – antibody diagnostics.
- HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060. April 2, 2020.
- HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060-P00001. June 19, 2020.
- HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060-P00002. July 24, 2020.
- New Horizons Diagnostics Corp. – diagnostic.
- Novavax – vaccine.
- DoD-Novavax Contract W911QY20C0077 (includes Mod 1). June 4, 2020.
- DoD-Novavax Contract W911QY20C0077 – Mods 1-4. June 4, 2020.
- Novavax – vaccine.
- DoD (via ATI)-Novavax Other Transaction Authority Agreement W15QKN1691002. June 25, 2020. (Version obtained via SEC filing)
- DoD (via ATI)-Novavax Technical Direction Letter W15QKN1691002. July 6, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
- DoD (via ATI)–Novavax Statement of Work W15QKN1691002. (Version obtained via FOIA lawsuit)
- DoD (via ATI)–Novavax Technical Direction Letters and Statements of Work W15QKN1691002. July 6, 2020 and December 21, 2020. (Version obtained via FOIA lawsuit)
- NOWDiagnostics – diagnostics.
- HHS/ASPR/BARDA-NOWDiagnostics Contract 75A50120C00156. August 27, 2020.
- Ology Bioservices (previously called Nanotherapeutics, Inc.) – vaccine manufacturing.
- DoD-Ology Bioservices Other Transaction Authority Agreement-W911QY2090003 Contract and Mods 1-5,8-10,12,14,15,17,23-25 . February 21, 2020
- DoD-Ology Bioservices Other Transaction Authority Agreement OTA-W911QY2090003. February 21, 2020.
- DoD-Ology Bioservices Other Transaction Authority Agreement Appendix OTA-W911QY2090003-Appendix-A-4. March 20, 2020.
- DoD-Ology Bioservices Contract W911QY2090003-MOD-P00005. March 22, 2020.
- Ology Bioservices (previously called Nanotherapeutics, Inc.) – vaccine manufacturing.
- DoD-Ology Bioservices Contract W911QY20C0101 (includes Mod 1). August 17, 2020.
- Ophirex – therapeutic.
- DoD-Ophirex Contract W81XWH20C0066 (includes Mods 1-3). June 19, 2020.
- Orasure – rapid antigen test.
- HHS/ASPR/BARDA-Orasure Contract 75A50120C00061. Date not listed.
- HHS/ASPR/BARDA-Orasure Contract 75A50120C00122. May 27, 2020.
- Ortho Clinical – antibody assays.
- HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120C00123. June 12, 2020.
- HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120C00123-P00001. August 28, 2020.
- HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120P00103. September 18, 2020.
- Oxford Nanopore Technologies – DNA sequencing.
- DoD-Oxford Nanopore Technologies Contract W911QX20P0073 (includes Mod 1). April 22, 2020.
- Partner Therapeutics, Inc. – therapeutic.
- DOD (via ATI)-Partner Therapeutics Technical Direction Letter OTA W15QKN1691002. August 13, 2020.
- Patricio Enterprises – COVID-19 mobile lab staffing.
- DoD-Patricio Enterprises Supply Order W911QY2OF0270-P00001 Contract W911QY18D0251. June 3, 2020.
- DOD-Patricio Enterprises Contract W911QY19F0133-P00037. December 7, 2020.
- Pfizer – vaccine.
- DoD (via ATI)-Pfizer Technical Direction Letter OTA W15QKN1691002. July 21, 2020.
- Pfizer – vaccines.
- DoD-Pfizer Contract W15QKN21C0012 (includes Mod 310). December 22, 2020.
- Pfizer – manufacturing.
- DVA-Pfizer Contract V797D40269-P00376. June 1, 2021.
- Pfizer – vaccine donation.
- DoD-Pfizer Contract W58P0521C0002. July 30, 2021.
- DOD-Pfizer Contract W58P0521C0002 Contract and P00376. July 30, 2021.
- Pharm Olam – therapeutic clinical trial.
- DOD-Pharm Olam Contract W911QY2190014. December 31, 2020.
- Philips North America – diagnostics technology.
- HHS/ASPR/BARDA-Philips North America Contract 75A50120C00097. May 7, 2020.
- DoD-Philips North America Project Approval Letter W81XWH1590001. August 27, 2020.
- DoD-Philips North America Revised Project Approval Letter (2) W81XWH1590001. September 23, 2020.
- DoD-Philips North America Revised Project Approval Letter (3) W81XWH1590001. October 13, 2020.
- DoD-Philips North America Statement of Work W81XWH1590001.
- Phlow Corporation – therapeutic.
- HHS/ASPR/BARDA-Phlow Corporation Contract 75A50120000092. May 18, 2020.
- Plasma Technologies – immune globulin hyperimmune manufacturing.
- DOD-Plasma Technologies Contract W911QY2020004. August 14, 2020.
- Protein Sciences Corporation (Sanofi) – vaccine.
- HHS/ASPR/BARDA-Protein Sciences Corp Contract HHSO100201600005I. February 14, 2020.
- HHS/ASPR/BARDA-Protein Sciences Corp Contract HHSO100201600005I. August 16, 2016.
- Qiagen – diagnostic R&D.
- HHS/ASPR/BARDA-Qiagen Contract 75A50120C00014. March 11, 2020.
- Quidel – antigen assay R&D.
- HHS/ASPR/BARDA-Quidel Contract 75A50120C00110. May 29, 2020.
- Regeneron Pharmaceuticals – therapeutic.
- HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C. September 21, 2017.
- HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C-MOD0006. January 31, 2020.
- HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C-MOD0006. (Date redacted).
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0002. April 22, 2019.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0003. May 18, 2019.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0001. September 28, 2018.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0005. February 12, 2020.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0008. June 15, 2020.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0009. June 19, 2020.
- HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0007. April 29, 2020.
- Regeneron – therapeutic manufacturing.
- DoD (via ATI)-Regeneron Other Transaction Authority Agreement W15QKN1691002 (contract and Technical Direction Letter). July 6, 2020.
- DoD (via ATI–Regeneron Technical Direction Letter W15QKN1691002. July 6, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
- Regeneron – prophylactic monoclonal antibody.
- DOD-Regeneron Pharmaceutical Contract W15QKN21C0014. January 12, 2021.
- DOD-Regeneron Pharmaceutical Contract W15QKN21C0014-P00004. July 26, 2021.
- Rigel Pharmaceuticals – therapeutic.
- DOD-Rigel Pharmaceuticals Other Transaction Authority Agreement W911QY2190018. January 29, 2021.
- DOD-Rigel Pharmaceuticals Other Transaction Authority Agreement W911QY2190018. January 29, 2021. (Version obtained via FOIA)
- SAB Biotherapeutics – antibody diagnostic.
- DOD (via ATI)-SAB Biotherapeutics Technical Direction Letter and Statement of Work – W15QKN1691002. April 18, 2020.
- Sanofi – vaccine.
- DOD (via ATI)-Sanofi Technical Direction Letter W15QKN1691002. July 30, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
- DOD (via ATI)-Sanofi Technical Direction Letter and Statement of Work RPP20-11 MCDC2011-005. December 18, 2020.
- Sempulse – diagnostics technology.
- DoD-Sempulse Project Approval Letter W81XWH1590001. September 23, 2020.
- DoD-Sempulse Statement of Work W81XWH1590001.
- Sepsis Alliance – sepsis training.
- HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C. January 19, 2019.
- HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C-P00001. June 6, 2019.
- HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C-P00002. May 7, 2020.
- Sibel – diagnostics technology.
- DoD-Sibel Project Approval Letter W81XWH1590001. August 27, 2020.
- DoD-Sibel Statement of Work W81XWH1590001.
- Siemens – immunoassay R&D.
- HHS/ASPR/BARDA-Siemens Contract 75A50120C00111. May 28, 2020.
- HHS/ASPR/BARDA-Siemens Contract 75A50120C00111-P00001. August 20, 2020.
- HHS/ASPR/BARDA-Siemens Contract 75A50120P00102. September 17, 2020.
- SIO2 – domestic pharmaceutical vials.
- DOD-SIO2 Medical Contract W911NF2030003 (includes Mods 1-3). June 5, 2020.
- Sonica – diagnostics.
- HHS/ASPR/BARDA-Sonica Contract 75A50119C00043. August 1, 2019.
- HHS/ASPR/BARDA-Sonica Contract 75A50119C00043-P00001. February 3, 2020.
- SourceAmerica – face coverings.
- DoD-SourceAmerica Contract W911QY20C0047 (includes Mods 1-5). April 17, 2020.
- DoD-SourceAmerica Contract W911QY20C0047-P00006. November 10, 2020.
- Tangen – assay.
- HHS/ASPR/BARDA-Tangen Biosciences Contract 75A50120C00085. April 15, 2020.
- Tasso – antibody test kits.
- DoD-Tasso Serology Contract W911QY20P0158 (includes Mods 1-4). May 1, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
- DoD-Tasso Serology Contract W911QY20P0158-P00005 and P00006. December 3, 2020. (Version obtained via FOIA)
- Texas A&M University System – expansion of manufacturing capacity (CIADM related).
- HHS/ASPR/BARDA-Texas A&M University System Contract HHSO100201200002I-75A50120F33002. July 23, 2020.
- HHS/ASPR/BARDA-Texas A&M University System Contract HHSO100201200002I-75A50120F33002-P0001. August 27, 2020.
- HHS/ASPR/BARDA-Texas A&M University System Contract HHSO100201200002I-75A50120F33002-P0002. October 9, 2020.
- Ultran Group – treatment device.
- DOD (via ATI)–Ultran Group Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. September 16, 2020.
- DOD (via ATI)–Ultran Group Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. September 16, 2020. (Version obtained via FOIA)
- University of California at San Francisco – diagnostics technology.
- University of Connecticut – vaccination technology.
- HHS/ASPR/BARDA-University of Connecticut Contract 75A50120C00162. August 16, 2020.
- Vaxess – spike protein vaccine manufacturing.
- HHS/ASPR/BARDA-Vaxess Technologies Contract 75A50120C00160. August 6, 2020.
- Vectrus-safety glasses.
- DOD-Vectrus Mission Solutions Contract W911QY18D0140 (includes Mod 1). April 22, 2020.
- VelocityDX – diagnostics.
- DoD-VelocityDX Contract W911QY20D0031. August 12, 2020.
- DoD-VelocityDX Contract W911QY20D0031. August 12, 2020. (Version obtained via FOIA)
- Visby – diagnostics.
- DoD-Visby Medical Contract W911QY20C0110 (includes Mod 1). September 20, 2020.
- DoD-Visby Medical Contract W911QY20C0110 (includes Mod 1). September 20, 2020. (Version obtained via FOIA)
- VitalConnect – vital sign threshold settings for COVID-19 patients.
- HHS/ASPR/BARDA-VitalConnect Contract 75A50120C00108. May 20, 2020.
- HHS/ASPR/BARDA-VitalConnect Contract 75A50120C00108-P00001. May 20, 2020.
- VxBiosciences – therapeutic.
- DoD-VxBiosciences Project Approval Letter W81XWH1590001. July 9, 2020.
- DoD-VxBiosciences Statement of Work W81XWH1590001.
- Vyaire Medical, Inc. – ventilators.
- HHS/ASPR/SNS-Vyaire Medical Contract 75A50120000049 (includes Mod 1). March 31, 2020.
- Waukesha Foundry – testing swabs.
- DOD-Waukesha Foundry Contract W911SR20P0009 (includes Mods 1-4). April 17, 2020.
- World Enterprises – volatile organic compound detection.
- DOD-World Enterprises W911SR21C0008 (includes Mods 1-3). November 13, 2020.
- 98Point6 – COVID-related Smartphone technology.
- HHS-98Point6 Contract 75A50120C001519. October 9, 2020.
US agreements not concerning COVID-19 research, but tied to related vaccine technologies:
- Moderna – Zika vaccine.
- HHS/ASPR/BARDA-Moderna Contract HHS0100201600029C. September 1, 2016.
US Government licenses related to COVID-19:
- NIH/NIAID-Geo Vax – vaccine primes/boosters.
- NIH/NIAID-AbCellera Biologics – vaccines and therapeutics.
- NIAID-AbCellera Patent License Agreement. May 4, 2020.
Europe
- European Commission-AstraZeneca- vaccine.
- European Commission-AstraZeneca Advance Purchase Agreement. August 27, 2020.
- European Commission-Curevac – vaccine.
- European Commission-Curevac Advance Purchase Agreement.
- European Commission-Sanofi Pasteur and GlaxoSmithKline – vaccines.
- European Commission-Sanofi Pasteur and GlaxoSmithKline Advance Purchase Agreement. September 18, 2020.
- European Investment Bank-BioNTech – financing vaccines.
- European Investment Bank-BioNTech Finance Contract. June 10, 2020.
- European Investment Bank-Curevac – financing vaccines.
- European Investment Bank-Curevac Finance Contract. June 27, 2020.
Australia
- Australia-Novavax – vaccine.
- Australia-Novavax Advanced Purchase Agreement. December 31, 2020.
Brazil
- Fundação Oswaldo Cruz (Fiocruz)-AstraZeneca – vaccine.
- Fiocruz-AstraZeneca Contract. September 8, 2020.
Canada
- Canada-Novavax – vaccine.
- Canada-Novavax Advanced Purchase Agreement. January 19, 2021.
China
- Beijing Youfeng-Generex – vaccine.
- NIVDCP-Beijing Youfeng-Generex Contract YF202011-A. November 13, 2020.
Dominican Republic
- Dominican Republic-Pfizer – vaccine.
- Dominican Republic-Pfizer Vaccine Term Sheet. January 19, 2021.
Israel
- Israel Ministry of Health-Pfizer – vaccine.
United Kingdom
- United Kingdom-Novavax – vaccine.
- United Kingdom-Novavax Supply Agreement. October 22, 2020.
Inter-company Agreements Concerning COVID-19
- AIM Immuno Tech-Roswell Park Cancer Institute Corporation/Roswell Park Comprehensive Cancer Center – clinical trials.
- AIM Immuno Tech-Amarex – clinical trials.
- AIM Immuno Tech-Amarex Project Work Order Proposal. August 4, 2020.
- Amerimmune-Histogen – therapeutics.
- Anixa Biosciences-OntoChem – therapeutics.
- Anixa-OntoChem Collaboration Agreement. April 14, 2020.
- AbCellera Biologics-Eli Lilly and Company – therapeutics.
- AbCellera-Eli Lilly Research Collaboration and License Agreement. March 11, 2020.
- GlaxoSmithKline-Vir Biotechnologies – vaccines and therapeutics.
- GlaxoSmithKline-Vir Preliminary Collaboration Agreement. April 5, 2020.
- Hoth Therapetics-George Washington University – smartphone-based direct virus sensing system.
- Hoth-GWU Sponsored Research Agreement. September 1, 2020.
- Hoth Therapeutics-Voltron Therapeutics – vaccines.
- Hoth-Voltron Development and Royalty Agreement. March [redacted], 2020.
- Kiromic Biopharma-Molipharma – vaccine, therapeutics, and diagnostics.
- Kiromic-Molipharma Joint Venture Agreement. April 2, 2020.
- Moderna-Lonza – mRNA vaccines and therapeutics.
- Moderna-Lonza Global Long Term Agreement. September 4, 2020.
- Nascent Biotech-Manhattan Biosolutions – vaccines and therapeutics.
- Nascent-Manhattan Research Collaboration Agreement. April 30, 2020.
- Novavax-Serum Institute of India – vaccine.
- Novavax-Serum Institute Supply and License Agreement. July 30, 2020.
- PharmaCyte Biotech-Hai Kang Life Corporation Limited – diagnostic.
- PharmaCyte-Hai Kang Life License Agreement. April 2, 2020.
- Pfizer – BioNTech – vaccine.
- Pfizer-BioNTech Collaboration Agreement. March 17, 2020.